News Daily News FDA Charts Path for ‘Resurrection’ of Device-Based Antihypertensive Therapies Michael O'Riordan December 06, 2018
News Features Country Roads: Vulnerable West Virginia Heart Patients Targeted in Outreach Program Michael O'Riordan October 29, 2018
News Conference News TCT 2018 PORTICO I: Low 1-Year Mortality With Repositionable TAVR Valve in OUS Experience L.A. McKeown September 27, 2018
News Conference News TCT 2018 TCT 2018: Mitral Interventions, Stent Wars, Practical Skills, and More Shelley Wood September 17, 2018
News Daily News Late Conduction Defects After TAVR: Finding ‘Sweet Spot’ for Early Discharge Michael O'Riordan August 08, 2018
News Daily News Lp(a) Might Not Be Good at Predicting Incident CVD in Low-Risk Women Yael L. Maxwell July 09, 2018
News Conference News The Structural Heart Disease Summit 2018 High-Quality TAVR: Does a Minimum Volume Requirement Still Make Sense? Michael O'Riordan June 22, 2018
Presentation The Structural Heart Disease Summit 2018 Pharmacotherapy Considerations Trials and Practical Clinical Recommendations Presenter: George D. Dangas June 21, 2018
News Conference News CRT 2018 Ticagrelor: Better Platelet Blockade Post-TAVR? Michael O'Riordan March 07, 2018
News Conference News CRT 2018 Early Low-Risk TAVR Data Reassure, but Durability Questions Remain Michael O'Riordan March 05, 2018
News Daily News Surprising Rate of Cardiac Amyloidosis in TAVR Patients Poses Tough Questions for Diagnosis, Decision-Making Michael O'Riordan February 01, 2018
News Daily News Structural Valve Degeneration: VIVID Group Proposes New, Graduated Definition Michael O'Riordan January 26, 2018
News Features Cardiologists Treating Syrian Refugees Call Missions an ‘Addictive’ Passion That Saves Lives Yael L. Maxwell January 12, 2018
News Daily News Role of Lp(a) Still to Be Determined, but NHLBI Sees a Path Forward Michael O'Riordan January 09, 2018